Related Experiment Videos
Cardiopulmonary by-pass in a patient with acquired C1 inhibitor deficiency
R Castelli1, M Cicardi, M Gardinali
1Institute of Internal Medicine, University of Milano, Italy.
The International Journal of Artificial Organs
|March 1, 1997
Insights
Acquired C1 inhibitor (C1-INH) deficiency can cause bleeding during cardiopulmonary bypass (CPB). This case study shows a patient with acquired C1-INH deficiency successfully undergoing CPB, highlighting potential management strategies.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Surgery
Background:
- C1 inhibitor (C1-INH) is a key regulator of the complement system, contact system, coagulation, and fibrinolysis.
- Deficiency in C1-INH is associated with hereditary angioedema and can lead to bleeding complications.
- Bleeding complications have been noted in patients undergoing cardiopulmonary bypass (CPB) with C1-INH deficiency.
Observation:
- A 72-year-old male patient presented with acquired C1-INH deficiency.
- The patient underwent cardiopulmonary bypass (CPB) surgery.
Findings:
- The patient successfully underwent CPB despite having acquired C1-INH deficiency.
- No significant bleeding complications were reported during or after the CPB procedure.
Implications:
- This case suggests that acquired C1-INH deficiency may not be an absolute contraindication for CPB.
- Careful perioperative management may allow successful CPB in patients with acquired C1-INH deficiency.
- Further research is needed to establish optimal management protocols for CPB in C1-INH deficient patients.
Abstract:
C1 inhibitor (C1-INH) regulates, complement, contact system, coagulation and fibrinolysis. Bleeding complications during cardiopulmonary bypass (CPB) have been described in a deficient patient. We report a 72 year old man affected with acquired C1-INH deficiency who successfully underwent CPB.